[ET Net News Agency, 13 August 2025] KEYMED BIO-B (02162) rose 10% to HK$73.
It hits an intra-day high of HK$73, hitting a 52-week high, and an intra-day low of
HK$66.35. The total shares traded was 3.89 million, with a value of HK$273.97m. The active
buy/sell ratio is 70:30, with net buying turnover of HK$106.23m. MACQUARIE CAPITAL
accounts for greatest net responsive buying turnover of HK$4.2m, with volume weighted
average price of HK$69.292. CHINA INV INFO accounts for greatest net responsive selling
turnover of HK$46.04m, with volume weighted average price of HK$70.502.

Basic Information
=================

----------------------------------
Nominal 73.000 % Chg +10.02%
High 73.000 Low 66.350
Shares Tr 3.89m Turnover 273.97m
10-D SMA 66.435 %H.V 76.018
20-D SMA 63.365 VWAP 70.400
50-D SMA 53.525 RSI14 71.871
----------------------------------
Status: Hitting a 52-week high, active buy/sell ratio is 70:30, with net buying turnover
of HK$106.23m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
KEYMED BIO-B (02162) 73.00 +10.02
SINO BIOPHARM (01177) 7.71 +2.94
3SBIO (01530) 30.92 +1.38
EVEREST MED (01952) 70.05 +3.17
WUXI XDC (02268) 61.70 +7.87
ASCENTAGE-B (06855) 81.10 +3.58
SKB BIO-B (06990) 420.20 +4.11
ZAI LAB (09688) 27.62 +3.06
AKESO (09926) 158.00 +0.96
REMEGEN (09995) 68.10 +3.34
---------------------------------------------
(ed)